Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.00
+0.26 (1.05%)
At close: May 29, 2026, 4:00 PM EDT
24.85
-0.15 (-0.60%)
After-hours: May 29, 2026, 6:34 PM EDT

Pulse Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-74.57-72.78-53.59-42.21-58.51-63.66
Depreciation & Amortization
1.041.071.181.211.361.15
Stock-Based Compensation
17.6921.4613.597.185.1914.6
Other Adjustments
1.531.150.930.018.660.01
Change in Receivables
-0.21-0.27-0.110.02-0.01
Changes in Inventories
-0.18-0.14---2.65-5.82
Changes in Accounts Payable
0.271.13-0.20.26-1.31.16
Changes in Accrued Expenses
1.43-3.453.211.22-1.79-0.94
Changes in Unearned Revenue
-----0.020.02
Changes in Other Operating Activities
-2.17-2.29-1.46-0.822.03-0.61
Operating Cash Flow
-55.2-54.12-36.34-33.04-47.01-54.1
Capital Expenditures
-0.3-0.32-0.13-0.12-0.4-0.44
Purchases of Intangible Assets
-0.01-0.02----
Purchases of Investments
-----8
Investing Cash Flow
-0.32-0.34-0.13-0.12-0.47.56
Long-Term Debt Issued
----651.94
Long-Term Debt Repaid
-----0.44-1.53
Net Long-Term Debt Issued (Repaid)
----64.560.41
Issuance of Common Stock
4.6217.15110.4216.3915.3862.51
Repurchase of Common Stock
------0.23
Net Common Stock Issued (Repurchased)
4.6217.15110.4216.3915.3862.28
Other Financing Activities
-0.06--0.28-0.01--
Financing Cash Flow
4.5617.15110.1416.3979.9462.69
Net Cash Flow
-50.96-37.373.67-16.7732.5316.15
Free Cash Flow
-55.5-54.44-36.47-33.16-47.41-54.53
FCF Margin
-----6773.43%-3845.84%
Free Cash Flow Per Share
-0.82-0.81-0.62-0.67-1.40-1.95
Levered Free Cash Flow
-74.47-76.77-50.98-40.473.28-68.73
Unlevered Free Cash Flow
-77.95-80.93-53.66-41.83-60.84-68.5
SEC Filings: 10-K · 10-Q